Greater Manchester GP Dr Helen Wall told the Manchester Evening News a number of viruses have skyrocketed this winter season.
Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate ...
Russell W. Jenkins, MD, Ph.D., a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...
CVGBM, an investigational cancer vaccine, induced T-cell responses in patients with MGMT-unmethylated glioblastoma.
ca.investing.com on MSN8h
Morgan Stanley upgrades Vir Biotechnology to 'overweight,' raises PT to $20Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from ...
Under the agreement, Ailux Biologics grants UCB a non-exclusive license to leverage XtalFold™ for the discovery and ...
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...
Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...
In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...
An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback